Purchase Order 75N95021P00338
Award Date 7/8/21
Potential Completion Date 8/7/21
Potential Value $244K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Center for Advancing Translational Sciences (NCATS) awarded a firm fixed-price purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on April 11, 2025, for HTRF MAB Anti 6HIS-TB and Streptavidin-XLent reagents totaling 20,000 points, with a contract ceiling value of $12,440.16. The contract will be completed by April 6, 2026, with performance taking place in Hopkinton, Massachusetts. This procurement does not utilize a small business set-aside...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc. for $20,685.50. The contract calls for Revvity to deliver 10,000 test kits of its proprietary Revvity HTRF SARS-CoV-2 capsid kit to the agency's specified delivery location in Rockville, Maryland by March 31, 2024. The solicitation sought this specific kit, which uses a homogeneous...
- Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $17,185 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to deliver 100,000 points worth of HTRF CAMP GI KIT assay kits. The kits will support drug abuse research programs at the National Institute on Drug Abuse. Delivery of the assay kits will take place in Baltimore, Maryland over the course of a one year ordering period. No subcontractors or...
- This firm fixed-price purchase order for $30,778.40 was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Discoverx Products, LLC. The contract is to provide one PathHunter detection kit (PN 93-0001XL) to support NCATS' high-throughput screening efforts for GPR151, a target related to pain and addiction under the NIH HEAL (Helping to End Addiction Long-term) Initiative. Eurofins Discoverx Products was...
- The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), awarded a $23,940.00 firm-fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for a View RNA in situ hybridization (ISH) cell assay kit. This acquisition supports NCATS' Cooperative Research and Development Agreement (CRADA) for Alagille syndrome (ALGS) research, specifically to screen compound libraries for activators of the...
- This federal contract award was made by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), a for-profit manufacturer and service provider of medical imaging products, laboratory equipment, and scientific instrumentation. The contract is for the provision of an "HTRF B-CATENIN TOTAL KIT - 10K PTS" and has a firm fixed price of $11,449.26. The contract does not have a set-aside...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...
- On September 17, 2014, the National Center for Advancing Translational Sciences (NCATS) awarded a Blanket Purchase Agreement (BPA) call contract valued at $24,100.20 to Revvity Health Sciences, Inc., doing business as PerkinElmer Inc. This firm fixed-price contract was issued without a small business set-aside designation and is scheduled for completion by March 31, 2015. The work will be performed in Shelton, Connecticut. As a child entity of Revvity Inc., Revvity Health Sciences specializes in...
- Promega Corporation received a firm fixed price contract award valued at $9,344.70 from the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health, for the procurement of ADP-Glo Kinase Assay kits containing 10,000 assays. The contract was awarded on August 20, 2015, with an ultimate completion date of February 29, 2016, and was executed as a call against Promega's existing $10 million Blanket Purchase Agreement with the NIH Office of...
- The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc. for annual preventative maintenance services on its existing Operetta CLS' and Opera Phenix automated imaging systems. The $530,109.36 contract has a period of performance from April 26, 2024 to April 25, 2025. This is a non-competitive, commercial services acquisition...